Search research articles
Contact Us
Filters
Showing results (21-30 of 38) with videos related to
Page
of 4
Sort By:
The Journal of Endocrinology
|
May 1, 1978
Steroidogenesis by cultured granulosa cells aspirated from human follicles using pregnenolone and androgens as precursors
R E Fowler, N L Fox, R G Edwards, et al.
Journal of Occupational Medicine. : Official Publication of the Industrial Medical Association
|
November 1, 1986
Occupational allergy to laboratory animals: an epidemiologic study
S M Bland, M S Levine, P D Wilson, et al.
AJR. American Journal of Roentgenology
|
July 9, 1999
Correlation of CT findings with clinical evaluations in 261 patients with symptomatic bronchiectasis
D A Lynch, J Newell, V Hale, et al.
European Heart Journal
|
June 29, 2001
The general concepts of an equivalence trial, applied to ASSENT-2, a large-scale mortality study comparing two fibrinolytic agents in acute myocardial infarction
E Lesaffre, E Bluhmki, F Wang-Clow, et al.
Journal of Clinical Pharmacology
|
May 12, 2000
Pharmacokinetics and pharmacodynamics of tenecteplase: results from a phase II study in patients with acute myocardial infarction
N B Modi, N L Fox, F W Clow, et al.
Journal of Thrombosis and Thrombolysis
|
June 22, 1999
Hemostatic effects of 1 mg daily warfarin on post CABG patients. Post CABG Studies Investigators
J M Walenga, D Hoppensteadt, R Pifarré, et al.
Journal of Occupational Medicine. : Official Publication of the Industrial Medical Association
|
March 1, 1986
Inhibition of esterase activity and an undercounting of circulating monocytes in a population of production workers
M S Levine, N L Fox, B Thompson, et al.
Lupus
|
May 30, 2018
A 6-month open-label extension study of the safety and efficacy of subcutaneous belimumab in patients with systemic lupus erythematosus
A Doria, D Bass, A Schwarting, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 28, 2009
Phase I and pharmacokinetic study of lexatumumab (HGS-ETR2) given every 2 weeks in patients with advanced solid tumors
H A Wakelee, A Patnaik, B I Sikic, et al.
American Heart Journal
|
January 3, 2001
Determination of a weight-adjusted dose of TNK-tissue plasminogen activator
F Wang-Clow, N L Fox, C P Cannon, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 38) with videos related to
Sort By:
Page
of 4
The Journal of Endocrinology
|
May 1, 1978
Steroidogenesis by cultured granulosa cells aspirated from human follicles using pregnenolone and androgens as precursors
R E Fowler, N L Fox, R G Edwards, et al.
Journal of Occupational Medicine. : Official Publication of the Industrial Medical Association
|
November 1, 1986
Occupational allergy to laboratory animals: an epidemiologic study
S M Bland, M S Levine, P D Wilson, et al.
AJR. American Journal of Roentgenology
|
July 9, 1999
Correlation of CT findings with clinical evaluations in 261 patients with symptomatic bronchiectasis
D A Lynch, J Newell, V Hale, et al.
European Heart Journal
|
June 29, 2001
The general concepts of an equivalence trial, applied to ASSENT-2, a large-scale mortality study comparing two fibrinolytic agents in acute myocardial infarction
E Lesaffre, E Bluhmki, F Wang-Clow, et al.
Journal of Clinical Pharmacology
|
May 12, 2000
Pharmacokinetics and pharmacodynamics of tenecteplase: results from a phase II study in patients with acute myocardial infarction
N B Modi, N L Fox, F W Clow, et al.
Journal of Thrombosis and Thrombolysis
|
June 22, 1999
Hemostatic effects of 1 mg daily warfarin on post CABG patients. Post CABG Studies Investigators
J M Walenga, D Hoppensteadt, R Pifarré, et al.
Journal of Occupational Medicine. : Official Publication of the Industrial Medical Association
|
March 1, 1986
Inhibition of esterase activity and an undercounting of circulating monocytes in a population of production workers
M S Levine, N L Fox, B Thompson, et al.
Lupus
|
May 30, 2018
A 6-month open-label extension study of the safety and efficacy of subcutaneous belimumab in patients with systemic lupus erythematosus
A Doria, D Bass, A Schwarting, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 28, 2009
Phase I and pharmacokinetic study of lexatumumab (HGS-ETR2) given every 2 weeks in patients with advanced solid tumors
H A Wakelee, A Patnaik, B I Sikic, et al.
American Heart Journal
|
January 3, 2001
Determination of a weight-adjusted dose of TNK-tissue plasminogen activator
F Wang-Clow, N L Fox, C P Cannon, et al.
Page
of 4